FRVLX
Price
$53.93
Change
-$0.18 (-0.33%)
Updated
Jun 25 closing price
Net Assets
3.73B
VISVX
Price
$46.21
Change
-$0.43 (-0.92%)
Updated
Jun 25 closing price
Net Assets
54.02B
Interact to see
Advertisement

FRVLX vs VISVX

Header iconFRVLX vs VISVX Comparison
Open Charts FRVLX vs VISVXBanner chart's image
Franklin Small Cap Value A
Price$53.93
Change-$0.18 (-0.33%)
VolumeN/A
Net Assets3.73B
Vanguard Small Cap Value Index I
Price$46.21
Change-$0.43 (-0.92%)
VolumeN/A
Net Assets54.02B
FRVLX vs VISVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FRVLX vs. VISVX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRVLX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 54B vs. FRVLX (3.73B). VISVX pays higher dividends than FRVLX: VISVX (2.11) vs FRVLX (0.90). FRVLX was incepted earlier than VISVX: FRVLX (29 years) vs VISVX (27 years). FRVLX (0.98) is less costly to investors than VISVX (0.19). FRVLX is a more actively managed with annual turnover of: 59.68 vs. VISVX (16.00). FRVLX has a lower initial minimum investment than VISVX: FRVLX (1000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 6.01 vs. FRVLX (-0.08). VISVX return over 5 years is better than : 88.70 vs. FRVLX (42.89).
FRVLXVISVXFRVLX / VISVX
Total Expense Ratio0.970.19511%
Annual Report Gross Expense Ratio0.980.19516%
Fund Existence29 years27 years-
Gain YTD-3.323-1.740191%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets3.73B54B7%
Annual Yield % from dividends0.902.1143%
Returns for 1 year-0.086.01-1%
Returns for 3 years14.0128.3549%
Returns for 5 years42.8988.7048%
Returns for 10 years0.1484.380%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGMX19.990.32
+1.63%
NYLI PineStone Global Equity Class R6
THISX77.301.17
+1.54%
T. Rowe Price Health Sciences I
SUHAX35.460.45
+1.29%
DWS Health and Wellness A
JGECX12.510.13
+1.05%
JHancock Global Equity C
AVUDX7.980.03
+0.35%
American Century Value R6